Cargando…
Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756943/ https://www.ncbi.nlm.nih.gov/pubmed/33353538 http://dx.doi.org/10.1186/s12888-020-02965-7 |
| _version_ | 1783626650406092800 |
|---|---|
| author | Iwanami, Akira Saito, Kazuhiko Fujiwara, Masakazu Okutsu, Daiki Ichikawa, Hironobu |
| author_facet | Iwanami, Akira Saito, Kazuhiko Fujiwara, Masakazu Okutsu, Daiki Ichikawa, Hironobu |
| author_sort | Iwanami, Akira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7756943 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77569432020-12-28 Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study Iwanami, Akira Saito, Kazuhiko Fujiwara, Masakazu Okutsu, Daiki Ichikawa, Hironobu BMC Psychiatry Correction BioMed Central 2020-12-22 /pmc/articles/PMC7756943/ /pubmed/33353538 http://dx.doi.org/10.1186/s12888-020-02965-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Iwanami, Akira Saito, Kazuhiko Fujiwara, Masakazu Okutsu, Daiki Ichikawa, Hironobu Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| title | Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| title_full | Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| title_fullStr | Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| title_full_unstemmed | Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| title_short | Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| title_sort | correction to: safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756943/ https://www.ncbi.nlm.nih.gov/pubmed/33353538 http://dx.doi.org/10.1186/s12888-020-02965-7 |
| work_keys_str_mv | AT iwanamiakira correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy AT saitokazuhiko correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy AT fujiwaramasakazu correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy AT okutsudaiki correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy AT ichikawahironobu correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy |